Actively Recruiting

Phase Not Applicable
Age: 18Years - 90Years
All Genders
NCT06392815

64Cu-DOTATATE-PET for Lyme Neuroborreliosis

Led by Rigshospitalet, Denmark · Updated on 2024-05-21

50

Participants Needed

1

Research Sites

136 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of the study is to investigate the applicability and performance of 64Cu-DOTATATE PET/CT/MR for diagnosis in patients with Lyme neuroborreliosis (LNB). In this prospective, observational cohort study with 64Cu-DOTATATE, the investigators wish to include a total of 50 patients clinically suspected of LNB. The investigators will investigate the diagnostic value of 64Cu-DOTATATE-PET comparing clinically suspected and CSF verified LNB patients with clinically suspected patients without CSF verification. The investigators hypothesize that the information obtained from 64Cu-DOTATATE PET/CT/MRI can improve the diagnostics of LNB as well as that 64Cu-DOTATATE PET/CT/MRI will be able to contribute to the follow-up of patients by adding prognostic information and the risk of persistent symptoms. The application of 64Cu-DOTATATE PET/CT/MRI in the diagnostic work-up of LNB would thus expectedly lead to a more precise diagnosis and risk assessment.

CONDITIONS

Official Title

64Cu-DOTATATE-PET for Lyme Neuroborreliosis

Who Can Participate

Age: 18Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Clinical suspicion of Lyme neuroborreliosis
  • Able to read, understand patient information, and give informed consent
Not Eligible

You will not qualify if you...

  • Pregnancy
  • Breastfeeding
  • Completed antibiotic treatment for Lyme neuroborreliosis
  • Weight exceeding 140 kg (scanner bed limit)
  • History of allergic reaction to compounds similar to 64Cu-DOTATATE
  • Contraindications to MRI (per checklist)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Anne-Mette Lebech

Copenhagen, Capital Region, Denmark, 2100

Actively Recruiting

Loading map...

Research Team

A

Anne-Mette Lebech

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here